Silence Therapeutics Plc Share Price

Silence Therapeutics Plc competes in the Manufacturing sector and Pharmaceutical Preparation Manufacturing industry. It is headquartered in 72 Hammersmith Road, United Kingdom and is traded on the London Stock Exchange, through the symbol SLN-LN.

Previous Close:
GBX£5.35 -0.0093% (November 29th, 2021)

Latest Share Trading Activity for Silence Therapeutics Plc

Day Open:
GBX£0.00(previous open GBX£5.41)
Day High:
GBX£0.00(previous high GBX£5.46)
Day Low:
GBX£0.00(previous low GBX£5.12)

About Silence Therapeutics Plc

Company Description
Silence Therapeutics is developing a new generation of medicines by harnessing the body's natural mechanism of RNA interference, or RNAi, to inhibit the expression of specific target genes thought to play a role in the pathology of diseases with significant unmet medical need. Silence's proprietary messenger RNAi GOLD™ (GalNAc Oligonucleotide Discovery) Platform can be used to create siRNAs that precisely target and silence disease-associated genes in the liver, which represents a substantial opportunity. Silence's wholly owned product candidates include SLN360 designed to address the high and prevalent unmet medical need in reducing cardiovascular risk in people born with high levels of
Chief Executive Officer (CEO)
David Solomon
Postal Address
London 72 Hammersmith Road United Kingdom
Phone Number

Silence Therapeutics Plc Historic Prices and Volume

Issue CountryGB
52 Week Range£4.11 - £6.80
52 Week Change£0.29
50 Day Moving Average£5.35
200 Day Moving Average£5.80
Average 10 Day Volume324070
Average 30 Day Volume240007
5 Day % Change-2%
30 Day % Change6%
3 Month % Change-9%
6 Month % Change-16%
1 Year % Change28%
2 Year % Change8%
5 Year % Change389%
Year To Date % Change4%

© 2024

While does what we can to maintain the high quality of the information displayed on this site, we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.